v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (5,170,970) $ (1,689,034)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 13,526 5,733
Amortization expense 719,028 283,176
Finance fee 182,922 80,063
Change in allowance for doubtful accounts 123,797 35,982
Stock compensation expense 507,670 272,983
Non-cash interest expense 226,466 15,535
Change in fair value of forward purchase agreement (300,000) 0
Changes in operating assets and liabilities:    
Accounts receivable (16,822) 36,449
Prepaid expenses and other current assets 1,005,715 (56,279)
Right of use asset, net of lease liability 1,030 1,981
Accounts payable and accrued expenses 1,650,714 (192,149)
Deferred revenue 66,894 53,345
NET CASH USED IN OPERATING ACTIVITIES (990,030) (1,152,215)
INVESTING ACTIVITIES    
Cash portion of consideration paid to acquire assets - Verifi Dental Limited (370,000) 0
Cash portion of consideration paid to acquire assets - FeatherPay (500,000) 0
Purchase of capital assets 0 (40,769)
Additions to capitalized software (334,437) (153,346)
NET CASH USED IN INVESTING ACTIVITIES (1,204,437) (194,115)
FINANCING ACTIVITES    
Net proceeds from debt 1,423,093 2,000,000
Payments on debt (309,953) (586,421)
Proceeds from issuance of common stock 0 540,000
NET CASH PROVIDED BY FINANCING ACTIVITIES 1,113,140 1,953,579
NET CHANGE IN CASH (1,081,327) 607,249
CASH AT BEGINNING OF THE PERIOD 1,219,358 196,153
CASH AT END OF THE PERIOD 138,031 803,402
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Cash paid during the period for interest $ 74,921 $ 215,821

Source